Liverpool goalkeeper Alisson Becker's father Jose found dead after drowning in Brazil

The Associated Press
·1 min read

Two Brazilian clubs have expressed condolences following the sudden death of the father of Liverpool goalkeeper Alisson Becker.

Fluminense posted on social media on Thursday that it's deeply sorry for the death of Jose Agostinho Becker.

Alisson's brother, Muriel, is a goalkeeper at Fluminense.

Internacional, where both Alisson and Muriel played, also offered condolences.

Brazilian media reported that 57-year-old Jose Agostinho Becker had drowned after going for a swim on his property in the city of Lavras do Sul, in the south of the country.

Local police confirmed the body of man was found on Wednesday night.

The 28-year-old Alisson played at Internacional between 2013 and 2016 before he joined Roma. He left Roma after two seasons to join Liverpool.

Alisson, who was a started for his national team in the 2018 World Cup, won the Champions League and latest edition of the Premier League with Liverpool.

Also See: Tottenham boss Jose Mourinho backs under fire goalkeeper Hugo Lloris despite errors in recent games

Premier League: Manchester City beat Tottenham to extend lead to seven points; Liverpool stunned by Leicester

Serie A: Inter Milan down arch-rivals AC Milan to extend lead to four points atop standings

Read more on Sports by Firstpost.

Latest Stories

  • DBS to buy 13% stake in privately-held Chinese lender for $814 million

    The company said financial authorities in Singapore and China had approved the deal and was in line with its aim to expand in the rapidly growing Greater Bay Area in China. In September, DBS received approval from China's securities regulator to form a joint venture securities company in which it would have a controlling stake, allowing DBS to engage in brokering, investment consulting, securities underwriting and sponsorship in the country. Earlier on Tuesday, Reuters exclusively reported DBS was among a clutch of banks looking to bid for parts of Citigroup's consumer business in Asia.

  • Global Oncolytic Virus Therapies Market Report 2021-2030: Lucrative Opportunities in Drug Approvals and Strong Pipeline of Oncolytic Virus Therapies - ResearchAndMarkets.com

    The "Global Oncolytic Virus Therapies Market: Focus on Commercialized Therapies, Pipeline Therapies, Type of Virus, Application, Region (15 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

  • NH Hotel Group Joins Global Hotel Alliance

    NH HOTEL GROUP JOINS GLOBAL HOTEL ALLIANCE

  • $973.6 Million Worldwide Mouth Ulcers Treatment Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com

    The "Mouth Ulcers Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

  • Derek Chauvin Judge Says Maxine Waters' Comment Could Lead To Trial Being Overturned

    The Democratic lawmaker called for protesters "to get more confrontational" at a weekend Minnesota rally.

  • Travelers Reports Strong First Quarter 2021 Net Income per Diluted Share of $2.87, up 23%, and Return on Equity of 10.2%

    The Travelers Companies, Inc. today reported net income of $733 million, or $2.87 per diluted share, for the quarter ended March 31, 2021, compared to $600 million, or $2.33 per diluted share, in the prior year quarter. Core income in the current quarter was $699 million, or $2.73 per diluted share, compared to $676 million, or $2.62 per diluted share, in the prior year quarter. Core income increased primarily due to higher net favorable prior year reserve development, a higher underlying underwriting gain (i.e., excluding net prior year reserve development and catastrophe losses) and higher net investment income, partially offset by higher catastrophe losses. Net realized investment gains in the current quarter were $44 million pre-tax ($34 million after-tax), compared to net realized investment losses of $98 million pre-tax ($76 million after-tax) in the prior year quarter. Per diluted share amounts benefited from the impact of share repurchases.

  • Line Of Duty Clue Points At Dark Truth About DCI Jo Davidson And Tommy Hunter Storyline

    More details about how the MIT officer was related to the deceased the OCG boss were hidden in episode five.

  • Sony is releasing its WH-1000XM4 headphones in white for a limited time

    Sony is releasing a white version of its WH-1000XM4 headphones for a limited time in Europe.

  • Cape Town wildfire: About 90% of blaze now contained

    CAPE TOWN, South Africa — Fire crews worked for a third day to extinguish a wildfire on the slopes of Cape Town's Table Mountain on Tuesday as the city came to terms with the damage caused by what officials have described as one of the area's worst blazes in years. About 90% of the fire had been contained, the Table Mountain National Park authority said, but only after firefighters worked through the night. Those firefighters faced "extreme circumstances," said the Working on Fire organization, which specializes in dealing with wildfires and has been helping the city's fire department. The operation on Table Mountain had now reached the “mop-up” stage, Working on Fire said. Fire-fighting helicopters were dropping water on areas where the fire still smouldered and smoked on the rocky peaks of Table Mountain. South African army choppers had joined the operation to support the fire department after the helicopters were all grounded Monday because of strong winds. That wind had dropped significantly, but a cloud of thick smoke still hung over the city. The wildfire started early Sunday and, fueled by strong winds, ripped down and across the slopes of the mountain toward residential areas overlooking downtown Cape Town. Neighborhoods were evacuated on Monday and people weren't yet able to return home. Firefighters mostly kept the flames at bay and away from homes — sometimes with just a few meters to spare. Around 250 firefighters were mobilized. The University of Cape Town campus was one of the first sites to be hit on Sunday and appears to have suffered the most damage. Numerous buildings at the university burned, including part of a near 100-year-old library containing rare books and manuscripts on African studies. The university said some of those “priceless” works had been lost, but it was unclear yet how much. Other historic buildings nearby, including a 225-year-old windmill and a restaurant near a memorial to British colonial politician Cecil Rhodes, also burned down. The South African government said a residence owned by its Department of Public Works and Infrastructure was completely destroyed by the fire. The house was empty at the time but family members of a national minister and two deputy ministers had to be evacuated from their homes nearby. The fire also came close to South African Deputy President David Mabuza's Cape Town residence, the government said. Around 600 hectares (1,482 acres) of land had burned, the Table Mountain National Park authority estimated. It said it would take days to completely put out the fire. The cause of the blaze is still unknown, although wildfires are reasonably common in the mountains and peaks around Cape Town during the hot, dry summer months and become especially dangerous and unpredictable when fueled by strong coastal winds, as happened on Sunday and Monday. Four firefighters were hurt battling the fire but no other casualties have been reported. Gerald Imray, The Associated Press

  • PayPal's Venmo launches crypto buying and selling

    Venmo, the peer-to-peer payment service owned by PayPal Holdings Inc, said on Tuesday it has started allowing users to buy, hold and sell cryptocurrencies on its app, a step that could inspire more mainstream adoption of the asset class. Venmo users will be able to buy bitcoin, ethereum, litecoin and bitcoin cash for as little as $1 and publish transactions on the app's feed, the company said. With more than 70 million customers, Venmo is one of the most popular payment apps in the United States, especially among younger consumers who use it to pay friends and family.

  • Alamos Gold Announces US$1 Billion Investment Treaty Claim Against the Republic of Turkey

    TORONTO, April 20, 2021 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or, including its direct and indirect subsidiaries, the “Company”) regrets to announce that its Netherlands wholly-owned subsidiaries Alamos Gold Holdings Coöperatief U.A, and Alamos Gold Holdings B.V. (the “Subsidiaries”) will file an investment treaty claim against the Republic of Turkey for expropriation and unfair and inequitable treatment, among other things, with respect to their Turkish gold mining project. The claim will be filed under the Netherlands-Turkey Bilateral Investment Treaty (the “Treaty”), and is expected to exceed $1 billion, representing the value of the Company’s Turkish assets. Alamos has had an active presence in Turkey since 2010. Over that time frame, the Company’s Turkish operations have met all legal and regulatory requirements, complied with best practices relating to sustainable development including meeting the highest environmental and social management standards, created hundreds of jobs, and developed trusting relationships with the local communities. Alamos and the Subsidiaries have invested over $250 million in Turkey, unlocked over a billion dollars worth of project value, and contributed over $20 million in royalties, taxes and forestry fees to the Turkish government. Over the life of the project, government revenues alone are expected to total $551 million. Additionally, Alamos and the Subsidiaries have invested $25 million to date towards various community and social initiatives. In October 2019, well into construction of the Kirazlı Gold Mine (“Kirazlı”), the government failed to grant a routine renewal of the Company’s mining licenses, despite the Company having met all legal and regulatory requirements for their renewal. This past October, the Turkish government refused the renewal of the Company’s Forestry Permit. The Company had been granted approval of all permits required to construct Kirazlı including the Environmental Impact Assessment approval, Forestry Permit, and GSM (Business Opening and Operation) permit, and certain key permits for the nearby Ağı Dağı and Çamyurt Gold Mines. These permits were granted by the Turkish government after the project earned the support of the local communities and passed an extensive multi-year environmental review and community consultation process. In its effort to secure the renewal of its mining licenses, the Company has attempted to work cooperatively with the Turkish government, has raised with the Turkish government its obligations under the Treaty, has sought to resolve the dispute by good faith negotiations, and has made considerable effort to build support among stakeholders and host communities. The Turkish government has failed to provide the Company with a reason for the non-renewal or a timeline for renewal of its licenses. The failure to renew the Company’s mining licenses will result in the loss of over a half a billion dollars in future economic benefits to the Republic of Turkey, including tax and other revenues, and thousands of jobs within Turkey. In addition to the lost job opportunities, this will also have a lasting impact on the local population through the disruption of ongoing investments into community projects. “Alamos began investing in Turkey in 2010, warmly welcomed by the Turkish government through its foreign investment office. After 10 years of effort and over $250 million invested by the Company we have been shut down for over 18 months in a manner without precedent in Turkey, despite having received all the permits required to build and operate a mine. The Company has worked in Turkey to the highest standard of conduct with respect to social and environmental best practices. Despite this effort, the Turkish government has given us no indication that relief is in sight, nor will they engage with us in an effort to renew the outstanding licenses. We are hopeful that the arbitration process will bring about the engagement that we have sought from the Turkish state, and lead to an equitable resolution to this impasse,” said John A. McCluskey, President and Chief Executive Officer of Alamos Gold. Alamos and the Subsidiaries are being represented by the leading Canadian law firm Torys LLP, with a team that includes John Terry and former Canadian Supreme Court Justice, the Hon. Frank Iacobucci. The Company is also being supported by its strategic advisor John Baird, former Canadian Minister of Foreign Affairs and Senior Advisor to Bennett Jones LLP. Bilateral investment treaties are agreements between countries to assist with the protection of investments. The Treaty establishes legal protections for investment between Turkey and the Netherlands. The Subsidiaries directly own and control the Company’s Turkish assets. The Subsidiaries invoking their rights pursuant to the Treaty does not mean that they relinquish their rights to the Turkish project, or otherwise cease the Turkish operations. The Company will continue to work towards a constructive resolution with the Republic of Turkey. If required, Alamos and the Subsidiaries are confident in the Subsidiaries’ ability to recover and enforce any favourable judgement pursuant to this Treaty, which will be rendered by three independent international arbitrators. Although timelines with respect to bilateral investment treaty arbitration can vary depending on procedural steps and delay tactics employed by nation states, it is estimated to have finality within five years. A portion of the cost of such an arbitral process is expected to be recovered as part of the arbitration process. The failure by the Republic of Turkey to renew the mining licenses in the 18 months since their expiry, the failure of discussions with the Republic of Turkey to date to resolve the situation, and the resulting current decision to proceed with a bilateral investment treaty claim is an impairment trigger for accounting purposes. As a result, Alamos and the Subsidiaries expect to incur an after-tax impairment charge of approximately $215 million, which will be recorded in the second quarter financial statements. The non-cash charge reflects Alamos’ and the Subsidiaries’ entire net carrying value of the Turkish assets. About Alamos Alamos is a Canadian-based intermediate gold producer with diversified production from three operating mines in North America. This includes the Young-Davidson and Island Gold mines in northern Ontario, Canada and the Mulatos mine in Sonora State, Mexico. Additionally, the Company has a significant portfolio of development stage projects in Canada, Mexico, Turkey, and the United States. Alamos employs more than 1,700 people and is committed to the highest standards of sustainable development. The Company’s shares are traded on the TSX and NYSE under the symbol “AGI”. Investor Contact Scott K. ParsonsVice President, Investor Relations (416) 368-9932 x 5439ir@alamosgold.com Media Contact Rebecca ThompsonVice President, Public Affairs (416) 368-9932 x 5448media@alamosgold.com All amounts are in United States dollars, unless otherwise stated. The TSX and NYSE have not reviewed and do not accept responsibility for the adequacy or accuracy of this release. Cautionary Note Regarding Forward Looking Statements This News Release contains statements about expected or anticipated future events, financial results and litigation outcomes that are forward-looking in nature and, as a result, are subject to certain risk and uncertainties such as the inherently uncertain nature of potential and ongoing litigation proceedings including outcomes and costs, general economic, political, market and business conditions, regulatory processes and actions, new legislation, government actions or inactions, technical issues, potential delays or changes in plans, the occurrence of unexpected events and the Company’s capability to execute and implement its future plans. The Republic of Turkey has recently experienced significant political, social, legal and regulatory instability. The impact of the change in political climate in Turkey in recent years is not fully known, but may include heightened control of the judiciary, bureaucracy, media and the private business sector. While the Company is taking the actions described in this News Release to mitigate the effects of the actions of the Turkish government in respect of the Company’s assets and gold mining projects in the Republic of Turkey, there can be no assurance that such mitigating actions will be effective or successful. If unsuccessful, the Company’s assets and gold mining projects in Turkey may be subject to resource nationalism and further expropriation; the Company may lose the full value of its assets and gold mining projects in Turkey and its ability to operate in Turkey. Even if successful, there is no certainty as to the quantum of any damages award, recovery of all, or any, legal costs. Any resumption of activities in Turkey, including renewal of the requisite operating licenses or permits, or even retaining control of its assets and gold mining projects in Turkey can only result from agreement with the Turkish government. The litigation described in this News Release may have an impact on foreign direct investment in the Republic of Turkey which may result in changes to the Turkish economy, including but not limited to high rates of inflation and fluctuation of the Turkish Lira which may also affect the Company’s relationship with the Turkish government, the Company’s ability to effectively operate in Turkey, and which may have a negative effect on overall anticipated project values. Additional risk factors affecting Alamos and the Company’s ability to achieve expectations set forth in the forward-looking statements contained in this News Release and in general are set out in the Company’s latest 40F/Annual Information Form and Management’s Discussion and Analysis, each under the heading “Risk Factors” available on SEDAR (www.sedar.com) or on EDGAR (www.sec.gov). The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

  • Pentair Announces Definitive Agreement to Acquire Assets of Ken’s Beverage, Inc.

    Pentair today announced that it has entered into a definitive agreement to acquire the assets of Ken’s Beverage, Inc.

  • Takeover of Asda 'could lead to higher petrol prices' - regulator

    The competition watchdog has raised fears that the ÂŁ6.8bn takeover of Asda could lead to higher petrol prices in some parts of the country. The Competition and Markets Authority, which has the power to block the deal as it did when Sainsbury's moved to merge with the chain in 2019, has been reviewing the sale by Walmart to a consortium led by the billionaire Issa brothers since December last year. The new owners - Mohsin and Zuber Issa and private equity firm TDR Capital - also own EG Group, which operates 395 petrol stations in the UK.

  • AECOM to host second quarter fiscal year 2021 earnings conference call on May 11th

    AECOM (NYSE:ACM), the world’s premier infrastructure consulting firm, today announced that it intends to release its second quarter fiscal 2021 financial results after market close on Monday, May 10, 2021. The Company will also host a conference call and webcast with analysts and investors on May 11, 2021 at noon Eastern Time, during which management will present the Company's second quarter fiscal 2021 financial results, and discuss trends across its business and markets.

  • Think Tank Launches New Manager Series V2 Rolling Cases

    The Manager Series from Think Tank Photo are three, professional strength, high capacity rolling cases designed for lighting gear, grip and large photographic equipment.

  • Global Urinary Drainage Bags Market to Reach $2.4 Billion by 2027

    Abstract: - Global Urinary Drainage Bags Market to Reach $2. 4 Billion by 2027. - Amid the COVID-19 crisis, the global market for Urinary Drainage Bags estimated at US$1. 8 Billion in the year 2020, is projected to reach a revised size of US$2.New York, April 20, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Urinary Drainage Bags Industry" - https://www.reportlinker.com/p06033202/?utm_source=GNW 4 Billion by 2027, growing at aCAGR of 4% over the period 2020-2027. Leg Bags, one of the segments analyzed in the report, is projected to record 4.3% CAGR and reach US$1.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Large Bags segment is readjusted to a revised 3.7% CAGR for the next 7-year period. - The U.S. Market is Estimated at $488.1 Million, While China is Forecast to Grow at 6.5% CAGR - The Urinary Drainage Bags market in the U.S. is estimated at US$488.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$484.3 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR. - Select Competitors (Total 36 Featured) - Amsino International, Inc.BDCardinal HealthColoplastConvaTecFlexicare Medical LimitedManfred Sauer GmbHMcKesson Medical-Surgical Inc.Medline Industries, Inc.Teleflex Incorporated Read the full report: https://www.reportlinker.com/p06033202/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Urinary Drainage Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Urinary Drainage Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Urinary Drainage Bags by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Leg Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Leg Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Leg Bags by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Large Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Large Bags by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Large Bags by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Disposable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Disposable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Disposable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Reusable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Reusable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Reusable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for 0-500 ml by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for 0-500 ml by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for 0-500 ml by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for 500-1000 ml by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 29: World Historic Review for 500-1000 ml by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: World 15-Year Perspective for 500-1000 ml by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 31: World Current & Future Analysis for 1000-2000 ml by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 32: World Historic Review for 1000-2000 ml by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: World 15-Year Perspective for 1000-2000 ml by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Table 34: USA Current & Future Analysis for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 35: USA Historic Review for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: USA 15-Year Perspective for Urinary Drainage Bags by Product Type - Percentage Breakdown of Value Sales for Leg Bags and Large Bags for the Years 2012, 2020 & 2027 Table 37: USA Current & Future Analysis for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: USA Historic Review for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: USA 15-Year Perspective for Urinary Drainage Bags by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2012, 2020 & 2027 Table 40: USA Current & Future Analysis for Urinary Drainage Bags by Usage - Disposable and Reusable - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: USA Historic Review for Urinary Drainage Bags by Usage - Disposable and Reusable Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: USA 15-Year Perspective for Urinary Drainage Bags by Usage - Percentage Breakdown of Value Sales for Disposable and Reusable for the Years 2012, 2020 & 2027 Table 43: USA Current & Future Analysis for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: USA Historic Review for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: USA 15-Year Perspective for Urinary Drainage Bags by Capacity - Percentage Breakdown of Value Sales for 0-500 ml, 500-1000 ml and 1000-2000 ml for the Years 2012, 2020 & 2027 CANADA Table 46: Canada Current & Future Analysis for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: Canada Historic Review for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: Canada 15-Year Perspective for Urinary Drainage Bags by Product Type - Percentage Breakdown of Value Sales for Leg Bags and Large Bags for the Years 2012, 2020 & 2027 Table 49: Canada Current & Future Analysis for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Canada Historic Review for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: Canada 15-Year Perspective for Urinary Drainage Bags by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2012, 2020 & 2027 Table 52: Canada Current & Future Analysis for Urinary Drainage Bags by Usage - Disposable and Reusable - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Canada Historic Review for Urinary Drainage Bags by Usage - Disposable and Reusable Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Canada 15-Year Perspective for Urinary Drainage Bags by Usage - Percentage Breakdown of Value Sales for Disposable and Reusable for the Years 2012, 2020 & 2027 Table 55: Canada Current & Future Analysis for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Canada Historic Review for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Canada 15-Year Perspective for Urinary Drainage Bags by Capacity - Percentage Breakdown of Value Sales for 0-500 ml, 500-1000 ml and 1000-2000 ml for the Years 2012, 2020 & 2027 JAPAN Table 58: Japan Current & Future Analysis for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Japan Historic Review for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Japan 15-Year Perspective for Urinary Drainage Bags by Product Type - Percentage Breakdown of Value Sales for Leg Bags and Large Bags for the Years 2012, 2020 & 2027 Table 61: Japan Current & Future Analysis for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: Japan Historic Review for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: Japan 15-Year Perspective for Urinary Drainage Bags by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2012, 2020 & 2027 Table 64: Japan Current & Future Analysis for Urinary Drainage Bags by Usage - Disposable and Reusable - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: Japan Historic Review for Urinary Drainage Bags by Usage - Disposable and Reusable Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: Japan 15-Year Perspective for Urinary Drainage Bags by Usage - Percentage Breakdown of Value Sales for Disposable and Reusable for the Years 2012, 2020 & 2027 Table 67: Japan Current & Future Analysis for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: Japan Historic Review for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: Japan 15-Year Perspective for Urinary Drainage Bags by Capacity - Percentage Breakdown of Value Sales for 0-500 ml, 500-1000 ml and 1000-2000 ml for the Years 2012, 2020 & 2027 CHINA Table 70: China Current & Future Analysis for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: China Historic Review for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: China 15-Year Perspective for Urinary Drainage Bags by Product Type - Percentage Breakdown of Value Sales for Leg Bags and Large Bags for the Years 2012, 2020 & 2027 Table 73: China Current & Future Analysis for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: China Historic Review for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: China 15-Year Perspective for Urinary Drainage Bags by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2012, 2020 & 2027 Table 76: China Current & Future Analysis for Urinary Drainage Bags by Usage - Disposable and Reusable - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: China Historic Review for Urinary Drainage Bags by Usage - Disposable and Reusable Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: China 15-Year Perspective for Urinary Drainage Bags by Usage - Percentage Breakdown of Value Sales for Disposable and Reusable for the Years 2012, 2020 & 2027 Table 79: China Current & Future Analysis for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: China Historic Review for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: China 15-Year Perspective for Urinary Drainage Bags by Capacity - Percentage Breakdown of Value Sales for 0-500 ml, 500-1000 ml and 1000-2000 ml for the Years 2012, 2020 & 2027 EUROPE Table 82: Europe Current & Future Analysis for Urinary Drainage Bags by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 83: Europe Historic Review for Urinary Drainage Bags by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: Europe 15-Year Perspective for Urinary Drainage Bags by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 85: Europe Current & Future Analysis for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: Europe Historic Review for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: Europe 15-Year Perspective for Urinary Drainage Bags by Product Type - Percentage Breakdown of Value Sales for Leg Bags and Large Bags for the Years 2012, 2020 & 2027 Table 88: Europe Current & Future Analysis for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: Europe Historic Review for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: Europe 15-Year Perspective for Urinary Drainage Bags by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2012, 2020 & 2027 Table 91: Europe Current & Future Analysis for Urinary Drainage Bags by Usage - Disposable and Reusable - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: Europe Historic Review for Urinary Drainage Bags by Usage - Disposable and Reusable Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: Europe 15-Year Perspective for Urinary Drainage Bags by Usage - Percentage Breakdown of Value Sales for Disposable and Reusable for the Years 2012, 2020 & 2027 Table 94: Europe Current & Future Analysis for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: Europe Historic Review for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: Europe 15-Year Perspective for Urinary Drainage Bags by Capacity - Percentage Breakdown of Value Sales for 0-500 ml, 500-1000 ml and 1000-2000 ml for the Years 2012, 2020 & 2027 FRANCE Table 97: France Current & Future Analysis for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: France Historic Review for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 99: France 15-Year Perspective for Urinary Drainage Bags by Product Type - Percentage Breakdown of Value Sales for Leg Bags and Large Bags for the Years 2012, 2020 & 2027 Table 100: France Current & Future Analysis for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 101: France Historic Review for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 102: France 15-Year Perspective for Urinary Drainage Bags by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2012, 2020 & 2027 Table 103: France Current & Future Analysis for Urinary Drainage Bags by Usage - Disposable and Reusable - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 104: France Historic Review for Urinary Drainage Bags by Usage - Disposable and Reusable Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 105: France 15-Year Perspective for Urinary Drainage Bags by Usage - Percentage Breakdown of Value Sales for Disposable and Reusable for the Years 2012, 2020 & 2027 Table 106: France Current & Future Analysis for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 107: France Historic Review for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 108: France 15-Year Perspective for Urinary Drainage Bags by Capacity - Percentage Breakdown of Value Sales for 0-500 ml, 500-1000 ml and 1000-2000 ml for the Years 2012, 2020 & 2027 GERMANY Table 109: Germany Current & Future Analysis for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 110: Germany Historic Review for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 111: Germany 15-Year Perspective for Urinary Drainage Bags by Product Type - Percentage Breakdown of Value Sales for Leg Bags and Large Bags for the Years 2012, 2020 & 2027 Table 112: Germany Current & Future Analysis for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 113: Germany Historic Review for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 114: Germany 15-Year Perspective for Urinary Drainage Bags by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2012, 2020 & 2027 Table 115: Germany Current & Future Analysis for Urinary Drainage Bags by Usage - Disposable and Reusable - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 116: Germany Historic Review for Urinary Drainage Bags by Usage - Disposable and Reusable Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 117: Germany 15-Year Perspective for Urinary Drainage Bags by Usage - Percentage Breakdown of Value Sales for Disposable and Reusable for the Years 2012, 2020 & 2027 Table 118: Germany Current & Future Analysis for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 119: Germany Historic Review for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 120: Germany 15-Year Perspective for Urinary Drainage Bags by Capacity - Percentage Breakdown of Value Sales for 0-500 ml, 500-1000 ml and 1000-2000 ml for the Years 2012, 2020 & 2027 ITALY Table 121: Italy Current & Future Analysis for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 122: Italy Historic Review for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 123: Italy 15-Year Perspective for Urinary Drainage Bags by Product Type - Percentage Breakdown of Value Sales for Leg Bags and Large Bags for the Years 2012, 2020 & 2027 Table 124: Italy Current & Future Analysis for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 125: Italy Historic Review for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 126: Italy 15-Year Perspective for Urinary Drainage Bags by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2012, 2020 & 2027 Table 127: Italy Current & Future Analysis for Urinary Drainage Bags by Usage - Disposable and Reusable - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 128: Italy Historic Review for Urinary Drainage Bags by Usage - Disposable and Reusable Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 129: Italy 15-Year Perspective for Urinary Drainage Bags by Usage - Percentage Breakdown of Value Sales for Disposable and Reusable for the Years 2012, 2020 & 2027 Table 130: Italy Current & Future Analysis for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 131: Italy Historic Review for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 132: Italy 15-Year Perspective for Urinary Drainage Bags by Capacity - Percentage Breakdown of Value Sales for 0-500 ml, 500-1000 ml and 1000-2000 ml for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 133: UK Current & Future Analysis for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 134: UK Historic Review for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 135: UK 15-Year Perspective for Urinary Drainage Bags by Product Type - Percentage Breakdown of Value Sales for Leg Bags and Large Bags for the Years 2012, 2020 & 2027 Table 136: UK Current & Future Analysis for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 137: UK Historic Review for Urinary Drainage Bags by End-Use - Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 138: UK 15-Year Perspective for Urinary Drainage Bags by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Clinics for the Years 2012, 2020 & 2027 Table 139: UK Current & Future Analysis for Urinary Drainage Bags by Usage - Disposable and Reusable - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 140: UK Historic Review for Urinary Drainage Bags by Usage - Disposable and Reusable Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 141: UK 15-Year Perspective for Urinary Drainage Bags by Usage - Percentage Breakdown of Value Sales for Disposable and Reusable for the Years 2012, 2020 & 2027 Table 142: UK Current & Future Analysis for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 143: UK Historic Review for Urinary Drainage Bags by Capacity - 0-500 ml, 500-1000 ml and 1000-2000 ml Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 144: UK 15-Year Perspective for Urinary Drainage Bags by Capacity - Percentage Breakdown of Value Sales for 0-500 ml, 500-1000 ml and 1000-2000 ml for the Years 2012, 2020 & 2027 SPAIN Table 145: Spain Current & Future Analysis for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 146: Spain Historic Review for Urinary Drainage Bags by Product Type - Leg Bags and Large Bags Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 147: Spain 15-Year Perspective for Urinary Drainage Bags Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p06033202/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Nationwide increases amount it will lend to first-time buyers

    Nationwide increases amount it will lend to first-time buyersUK’s biggest building society says it will allow new buyers to take out loans worth up to 5.5 times their earnings Several big lenders launched 95% mortgages on Monday using the government’s guarantee scheme to back the deals. Photograph: Andrew Fosker/Rex/Shutterstock

  • UPDATE 1-Soccer-UEFA chief urges English breakaway 'Big Six' to think again

    UEFA president Aleksander Ceferin on Tuesday told the English Premier League's "Big Six" clubs who have joined a breakaway European Super League that they had made a "huge mistake", and urged them to think again. Speaking at UEFA's congress, the Slovenian criticised the attitude of owners who he said view the game as a "product" and fans as "consumers" but then spoke directly to the Premier League rebels. "What matters is that there is still time to change your mind, everyone makes mistakes, English fans deserve to have you correct your mistake, they deserve respect."

  • How England, Scotland and Wales could line up without breakaway clubs’ players

    International managers are little more than a month away from naming their squads for this summer’s rearranged European Championship.

  • Global Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2021-2027: U.S. Market is Estimated at $360.6 Million, While China is Forecast to Grow at 9.7% CAGR

    Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus (RSV) Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Respiratory Syncytial Virus (RSV) Therapeutics Market to Reach $2.4 Billion by 2027Amid the COVID-19 crisis, the global market for Respiratory Syncytial Virus (RSV) Therapeutics estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 10.4% over the analysis period 2020-2027. Palivizumab, one of the segments analyzed in the report, is projected to record a 11.4% CAGR and reach US$1.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ribavirin segment is readjusted to a revised 8.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $360.6 Million, While China is Forecast to Grow at 9.7% CAGRThe Respiratory Syncytial Virus (RSV) Therapeutics market in the U.S. is estimated at US$360.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$416.3 Million by the year 2027 trailing a CAGR of 9.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.5% and 8.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.Other Drug Types Segment to Record 7.5% CAGRIn the global Other Drug Types segment, USA, Canada, Japan, China and Europe will drive the 7.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$99.7 Million in the year 2020 will reach a projected size of US$166 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$279.6 Million by the year 2027.Key Topics Covered: I. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Influencer Market InsightsWorld Market TrajectoriesImpact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS(Total 41 Featured): AbbVie, Inc.AstraZeneca PLCBausch Health Companies Inc.F. Hoffmann-La Roche AGGilead Sciences, Inc.GlaxoSmithKline PLCMerck & Co., Inc.ReViral Ltd.Teva Pharmaceutical Industries Ltd. 3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE World 15-Year Perspective for Respiratory Syncytial Virus (RSV) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027World 15-Year Perspective for Palivizumab by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027World 15-Year Perspective for Ribavirin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027World 15-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027World 15-Year Perspective for InjecTable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027World 15-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 III. GEOGRAPHIC MARKET ANALYSIS IV. COMPETITION Total Companies Profiled: 41 For more information about this report visit https://www.researchandmarkets.com/r/xu9r88 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900